Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools



Rating:

Share or cite this content

Citations should be made in the following way:
J. H. Hull, R. Garrod, T. Ho, R. Knight, J. R. Cockcroft, D. J. Shale, C. E. Bolton (London, Surrey, Cardiff, United Kingdom). Increased arterial stiffness in adult patients with cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 2858

Member's Comments

No comment yet.

Related content which might interest you: Increased arterial stiffness in children with cystic fibrosis Source: Eur Respir J 2012; 39: 1536-1537 Year: 2012 Increased augmentation index in patients with cystic fibrosis Source: Eur Respir J 2009; 34: 1322-1328 Year: 2009 Pulmonary hypertension in cystic fibrosis patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Exercise capacity and pulmonary artery pressure in adults with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Microcirculation alterations in adult patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 262s Year: 2006 Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Relationship between respiratory muscle strength and pulmonary function in children with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 730s Year: 2006 Electrocardiographical characteristics of pulmonary arterial hypertension in children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Glycaemic variability indices are associated with increased pulmonary function decline in people with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis: diagnosis and monitoring Year: 2018 Relationship between pulmonary functions and respiratory muscle strength in children with non cystic fibrosis bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 698s Year: 2004 Skeletal muscle metabolism in active cystic fibrosis (CF) patients with light/moderate pulmonary dysfunction Source: International Congress 2015 – Clinical exercise physiology in health and disease Year: 2015 Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008